Can it get any worse for CSL?
Are bad times behind this leading global biotechnology company founded in Australia in 1916?
Monday Edition, 16 February 2026
“HOT” stock: Breville Group (BRG)
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, explains why Morgans maintains its BUY rating for Breville Group (BRG).
3 potential medical device stars
Here are three promising (though not yet profitable and speculative) companies trying to emulate that success of medical device companies such as Cochlear and RedMed.
Buy, Hold, Sell…What The Brokers Say
For the week ending Friday, February 13, 2026, FNArena tracked 31 upgrades and 12 downgrades for ASX-listed companies from brokers monitored daily.
Switzer Investing TV 16/02/26 | What top stock pickers are buying in this chaotic market
On this week’s Switzer Investing TV, Peter Switzer speaks with Jun Bei Liu of Ten Cap and Paul Rickard about how they would position portfolios.
Switzer on Saturday, 14 February 2026
This is where you remember who you are
It was another crazy week when speculation continued about how good businesses could be attacked by AI-driven rivals.
Thursday Edition, 12 February 2026
Contrarian opportunities for tech bargain hunters
While Artificial Intelligence fears may drive software-as-a-service stocks below their real worth, index investing can still play a role.
“HOT” stock: Orica (ORI)
In our “HOT” stock article, Michael Gable, Managing Director of Fairmont Equities, explains in more detail why he believes that ORI is just undergoing a healthy consolidation and is ready to move higher again.
Questions of the Week
Are interest rates going up good or bad for the banks? What’s the best 12-month term deposit rate? Following CAR Group’s strong profit result, what do the broker analysts now have as their target price? Is it too late to get out of CBA’s dividend re-investment plan and take the $2.35 dividend in cash instead?
Boom, Doom, Zoom! | 12 Feb 2026: Banks boom, CSL smashed, tech gets tense
This week on Boom Doom Zoom, Paul Rickard and Peter Switzer tackle a market that’s rotating aggressively. Banks are back in favour. Resources are surging. Healthcare and SaaS names? Getting smashed.
Monday Edition, 9 February 2026
Three potential oil and gas stars
Here are three stocks positioned nicely to bring gas to hungry markets. These are unprofitable, speculative stocks – with attractive potential attributes – so, as always, do your own homework!
“HOT” stock: Pro Medicus (PMD)
In our “HOT” stock column today, Raymond Chan, Adviser & Head of Asian Desk, notes that Morgans has added Pro Medicus (PME) to the Best Ideas List.
Concerned about the ‘Magnificent 7’? Here are some alternatives
Seven magnificent tech giants have powered the rise of the US stock market. They’re now a tick over a third of the benchmark US S&P 500 index. This year they’re off to a mixed start. If you’re concerned you might have too much exposure to them, here are some index tracking ETFs to consider.
Buy, Hold, Sell…What The Brokers Say
For the week ending Friday 6th February 2026, FNArena tracked 23 upgrades and 14 downgrades for ASX-listed companies from brokers monitored daily.
Will AI KO Xero, WiseTech and NextDC?
Today I’m standing on the shoulders of great business builders to argue that this tech sell off is a buying opportunity. Stay with me on this!